IRIS UniCatt

Fresa, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.436
NA - Nord America 1.273
EU - Europa 834
SA - Sud America 327
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.910
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.217
SG - Singapore 647
CN - Cina 320
IT - Italia 264
BR - Brasile 253
VN - Vietnam 146
DE - Germania 121
FR - Francia 113
SE - Svezia 87
IN - India 84
FI - Finlandia 71
JP - Giappone 53
ID - Indonesia 40
GB - Regno Unito 34
IE - Irlanda 33
AR - Argentina 31
KR - Corea 30
CA - Canada 29
RU - Federazione Russa 25
HK - Hong Kong 22
MX - Messico 22
BD - Bangladesh 18
NL - Olanda 15
AT - Austria 13
EC - Ecuador 13
PL - Polonia 13
ZA - Sudafrica 13
IQ - Iraq 11
TR - Turchia 11
CO - Colombia 10
CZ - Repubblica Ceca 10
ES - Italia 8
VE - Venezuela 6
BE - Belgio 5
DZ - Algeria 5
NP - Nepal 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
IR - Iran 4
UZ - Uzbekistan 4
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
QA - Qatar 3
SA - Arabia Saudita 3
TN - Tunisia 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
MC - Monaco 1
MD - Moldavia 1
MR - Mauritania 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.910
Salva come PNG Salva come JPEG
Città #
Singapore 381
San Jose 181
Ashburn 136
Rome 96
Chandler 80
Hefei 76
Beijing 61
Hyderabad 53
Tokyo 52
Ho Chi Minh City 49
New York 48
Los Angeles 47
Chicago 44
Council Bluffs 44
Lauterbourg 44
Hanoi 41
Frankfurt am Main 39
Florence 36
Munich 36
Jakarta 34
Dublin 31
Seoul 30
Helsinki 29
Milan 29
The Dalles 27
Dallas 24
Turku 23
Kent 22
Lappeenranta 19
São Paulo 18
Hong Kong 17
St Louis 16
Nuremberg 15
Buffalo 14
Santa Clara 14
Montreal 13
Moscow 13
Rio de Janeiro 13
Boston 12
Tampa 12
Bremen 11
Princeton 11
Atlanta 10
Brooklyn 10
Phoenix 10
Salt Lake City 10
Düsseldorf 9
Elk Grove Village 9
Marseille 9
Orem 9
Stockholm 9
Vienna 9
Wilmington 9
Denver 8
Johannesburg 8
San Mateo 8
Warsaw 8
London 7
Naples 7
Poplar 7
Shanghai 7
Amsterdam 6
Brno 6
Haiphong 6
Manchester 6
Mexico City 6
Toronto 6
Washington 6
Belo Horizonte 5
Bogotá 5
Brussels 5
Buenos Aires 5
Campinas 5
Chennai 5
Curitiba 5
Da Nang 5
Dulles 5
Guayaquil 5
North Hollywood 5
Paris 5
Pavia 5
Baghdad 4
Brasília 4
Brdo 4
Bắc Giang 4
Dhaka 4
Guangzhou 4
Manaus 4
Mumbai 4
New Delhi 4
Porto Alegre 4
Quito 4
Tashkent 4
Turin 4
Ankara 3
Arezzo 3
Bexley 3
Can Tho 3
Canoas 3
Central 3
Totale 2.331
Salva come PNG Salva come JPEG
Nome #
Role of microRNAs in Chronic Lymphocytic Leukemia 155
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 125
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 121
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 118
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 116
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 111
the concomitance of lymphoma and breast carcinoma in the bone 111
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 110
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 110
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 105
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 105
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study 100
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 99
Richter transformation in Chronic Lymphocytic Leukemia 99
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 99
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 98
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 97
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 91
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 89
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 88
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 88
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 88
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 88
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 87
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? 86
The concomitance of lymphoma and breast carcinoma in the bone 86
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 83
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 83
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 83
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 81
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 79
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 78
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 78
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 78
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 73
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study 71
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study 70
CAR-T Cells in Chronic Lymphocytic Leukemia 67
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 47
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort 44
Measurable residual disease in chronic lymphocytic leukemia 24
Totale 3.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/202282 0 3 3 2 7 0 1 9 5 0 34 18
2022/2023290 34 34 13 31 25 25 12 20 45 17 31 3
2023/2024363 6 64 22 37 15 55 31 21 2 26 31 53
2024/20251.088 21 19 57 55 65 39 44 27 93 122 373 173
2025/20262.140 299 98 181 288 345 144 368 131 133 153 0 0
Totale 3.988